← Back to Screener
Aclarion, Inc. Common Stock (ACON)
Price$3.55
Favorite Metrics
Price vs S&P 500 (26W)-69.32%
Price vs S&P 500 (4W)-3.56%
Market Capitalization$7.74M
All Metrics
Book Value / Share (Quarterly)$15.02
P/TBV (Annual)4.47x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)7.83%
Cash Flow / Share (Quarterly)$-8.62
Price vs S&P 500 (YTD)-30.44%
Gross Margin (TTM)9.01%
Net Profit Margin (TTM)-9551.87%
EPS (TTM)$-17.51
10-Day Avg Trading Volume0.15M
EPS Excl Extra (TTM)$-17.51
Revenue Growth (5Y)9.28%
EPS (Annual)$-13.60
ROI (Annual)-720.92%
Gross Margin (Annual)9.02%
Net Profit Margin (5Y Avg)-10254.64%
Cash / Share (Quarterly)$14.08
Revenue Growth QoQ (YoY)80.65%
ROA (Last FY)-329.86%
Revenue Growth TTM (YoY)65.57%
EBITD / Share (TTM)$-13.94
Operating Margin (TTM)-10103.99%
Cash Flow / Share (Annual)$-4.56
P/B Ratio0.60x
P/B Ratio (Quarterly)0.24x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)-56.50x
Net Interest Coverage (TTM)-12.07x
ROA (TTM)-49.80%
EPS Incl Extra (Annual)$-13.60
Current Ratio (Annual)0.71x
Quick Ratio (Quarterly)14.43x
3-Month Avg Trading Volume0.62M
52-Week Price Return-62.75%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$13.56
P/S Ratio (Annual)102.17x
Asset Turnover (Annual)0.02x
52-Week High$12.03
Operating Margin (5Y Avg)-8982.77%
EPS Excl Extra (Annual)$-13.60
CapEx CAGR (5Y)2.64%
26-Week Price Return-60.57%
Quick Ratio (Annual)0.56x
13-Week Price Return-18.90%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)14.81x
Enterprise Value$-4.279
Revenue / Share Growth (5Y)7.44%
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-9551.87%
Cash / Share (Annual)$1.30
3-Month Return Std Dev81.35%
Gross Margin (5Y Avg)-19.88%
Net Income / Employee (TTM)$-1
ROE (Last FY)-720.92%
Net Interest Coverage (Annual)-31.92x
EPS Basic Excl Extra (Annual)$-13.60
Receivables Turnover (TTM)3.15x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-17.51
Receivables Turnover (Annual)4.73x
ROI (TTM)-52.32%
P/S Ratio (TTM)102.17x
Pretax Margin (5Y Avg)-10254.64%
Revenue / Share (Annual)$0.14
Tangible BV / Share (Annual)$2.07
Price vs S&P 500 (52W)-97.84%
Year-to-Date Return-26.30%
5-Day Price Return5.61%
EPS Normalized (Annual)$-13.60
ROA (5Y Avg)-278.57%
Net Profit Margin (Annual)-9551.87%
Month-to-Date Return3.67%
Cash Flow / Share (TTM)$-0.52
EBITD / Share (Annual)$-13.94
Operating Margin (Annual)-10103.97%
EPS Basic Excl Extra (TTM)$-17.51
P/TBV (Quarterly)0.27x
P/B Ratio (Annual)1.55x
Pretax Margin (TTM)-9551.87%
Book Value / Share (Annual)$4.53
Price vs S&P 500 (13W)-21.76%
Beta1.27x
Revenue / Share (TTM)$0.10
ROE (TTM)-52.32%
52-Week Low$2.34
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
ACONAclarion, Inc. Common Stock | — | 65.57% | -10103.99% | -52.32% | $3.55 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $207.74 |
LHLabcorp Holdings Inc. | 25.31x | 7.25% | 9.92% | 10.28% | $269.19 |
DGXQuest Diagnostics Inc. | 21.75x | 11.78% | 14.10% | 13.88% | $196.31 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $91.07 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $57.85 |
VCYTVeracyte, Inc. | 39.66x | 16.01% | 11.17% | 5.33% | $33.45 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $51.20 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $21.29 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.44 |
About
Aclarion Inc provides Nociscan, a SaaS diagnostic platform that uses proprietary Magnetic Resonance Spectroscopy technology to help physicians noninvasively identify painful spinal discs. The company generates revenue by delivering diagnostic reports to medical professionals in the United States.